Special Products Limited (SPL) is a UK speciality pharmaceutical company with a focus on the development and distribution of high quality unlicensed medicines for patients with special clinical requirements that licensed medicines cannot meet.
Special Products Limited sources and supplies a range of high quality, UK batch manufactured unlicensed medicines. Although not restricted to any particular disease area or patient group, Special Products Limited is well represented in the therapeutic areas of Central Nervous System (CNS) and Inborn Errors of Metabolism (IEM), and the neonatal and paediatric patient groups.
Special Products Limited’s high quality batch manufactured unlicensed medicines are delivered with Certificates of Analysis, supported by stability data and backed by validated and extended shelf lives. Datasheets are supplied on a request basis through our medical information service and all enquiries are dealt in a professional and timely manner.